Vimarsana
Biggest News Aggregation in the World

Page 2 - Genentech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genentech Today - Breaking & Trending Today

DiMe, Big Pharmas collab on framework for digital endpoints - Vimarsana News

DiMe, Big Pharmas collab on framework for digital endpoints

Abbvie and other big names in biopharma will work on a Digital Medicine Society project that aims to set industry benchmarks for digital endpoints.

DelveInsight Business Research, LLP: Adrenocortical Carcinoma Market to Exhibit Growth at a CAGR of 11.1% by 2034 - Vimarsana News

DelveInsight Business Research, LLP: Adrenocortical Carcinoma Market to Exhibit Growth at a CAGR of 11.1% by 2034

According to DelveInsight's' estimates, the adrenocortical carcinoma market in 7MM is expected to show positive growth, during the forecast period (2024-2034), mainly attributed to the anticipated

Five-year data from Genentech SMA study released - Vimarsana News

Five-year data from Genentech SMA study released

SMA patients in the long-term extension Evrysdi study maintained or improved key developmental skills over the five-year period, data shows.

Negligence — Medical malpractice – Expert | Michigan Lawyers Weekly - Vimarsana News

Negligence — Medical malpractice – Expert | Michigan Lawyers Weekly

Where summary disposition was awarded to the defendants in a medical malpractice case, the trial court did not abuse its discretion when it ruled that expert testimony proffered by the plaintiff was inadmissible, so the judgment should be affirmed absent evidence of causation.

Climate Change Fuels Surge in Multiple Sclerosis Cases - Vimarsana News

Climate Change Fuels Surge in Multiple Sclerosis Cases

Climate change-induced exacerbations will increase the number of multiple sclerosis cases.